PT-141 (Bremelanotide) Research & Scientific Overview Jump to: Structure | Mechanism | Studies | Pharmacokinetics | Protocols | Limitations | Lead Researcher | References PT-141 (Bremelanotide) Molecular Structure & Chemical Properties PT-141 represents a significant milestone in sexual dysfunction research as the first FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder
For those who are visual learners, our team breaks down similar lab safety and handling procedures on our YouTube channel, which can help reinforce these sterile techniques
Peptides.org makes no claims that any products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials
It leverages the bodys central pathways (melanocortin and dopamine systems) to produce an erection and heighten libido, rather than directly affecting the penis blood vessels
It is closer to a coin flip
Based on the available evidence, Melanotan 2 has been dosed in past studies in the following manner: Once per day, in the morning, afternoon, or evening: Most researchers have administered MT-2 in the morning or afternoon before sun exposure to increase results